Skip to main content
TipRanks
Go Ultimate75% OFF

Paysign (PAYS) Stock Price & Analysis

1,154 Followers

PAYS Stock Chart & Stats

$10.06-$0.01(-0.10%)
At close: 4:00 PM EST
$10$12.5$15Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$9.98 - $10.37
52-Week Range
$3.08 - $16.15
Previous Close
$10.07
Volume
N/A
Average Volume (3M)
1.23M
Market Cap
$571.95M
Enterprise Value
$614.62M
Total Cash (Recent Filing)
$34.54M
Total Debt (Recent Filing)
$5.50M
Price to Earnings (P/E)
27.6
Beta
1.42
Next Earnings
Mar 23, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Patient Affordability Growth

Rapid growth in patient affordability revenue and a larger program base indicate strong adoption of Paysign’s healthcare payments platform. Continued launches, maturation of existing programs and pharmaceutical relationship expansion can support recurring, scalable revenue over the next several quarters.

Margin Expansion And Operating Leverage

Sharp margin expansion shows that revenue growth is translating into disproportionate profit growth as higher-margin pharmaceutical services increase their mix. Expense growth below revenue growth and a raised profitability outlook support the durability of operating leverage.

Strong Cash Generation And Low Leverage

Robust free cash flow closely tracking earnings gives Paysign resources to fund product development, support client programs and pursue expansion without relying heavily on external financing. Very low leverage also preserves flexibility through changing business conditions.

Bears Say

Loss Of 113 Plasma Centers

The center transition reduces the scale of Paysign’s plasma processing business and removes an established source of program and transaction revenue. Although some centers remain, the event demonstrates that client decisions can create meaningful structural pressure on an important business line.

Apherion Regulatory Uncertainty

Pending regulatory approval delays the timing of Apherion commercialization and leaves the potential contribution from the donor management system uncertain. A slower review could postpone European and broader product expansion, limiting near-term diversification beyond existing programs.

Revenue Growth Deceleration

A material slowdown in top-line growth raises the importance of new program wins and successful product expansion to sustain earnings momentum. If moderate growth persists while the asset base expands, maintaining returns and the current profitability trajectory may become more difficult.

Paysign News

PAYS FAQ

What was Paysign’s price range in the past 12 months?
Paysign lowest stock price was $3.08 and its highest was $16.15 in the past 12 months.
What is Paysign’s market cap?
Paysign’s market cap is $571.95M.
When is Paysign’s upcoming earnings report date?
Paysign’s next earnings report is estimated for Mar 23, 2027 (not yet confirmed), which is in 123 days.
How were Paysign’s earnings last quarter?
Paysign released its earnings results on Nov 09, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02.
Is Paysign overvalued?
According to Wall Street analysts Paysign’s price is currently Undervalued.
Does Paysign pay dividends?
Paysign does not currently pay dividends.
What is Paysign’s EPS estimate?
Paysign’s EPS estimate is 0.07.
How many shares outstanding does Paysign have?
Paysign has 56,854,336 shares outstanding.
What happened to Paysign’s price movement after its last earnings report?
Paysign reported an EPS of $0.11 in its last earnings report, beating expectations of $0.09. Following the earnings report the stock price went down -18.945%.
Which hedge fund is a major shareholder of Paysign?
Hedge funds hold Paysign shares: the largest hedge-fund position in Paysign is 72,326,070 shares, and hedge funds increased their holdings by 556.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology